Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Tapentadol 250mg modified-release capsules |
| BNF code | 0407020AHAAAEAE |
| Virtual Therapeutic Moiety | Tapentadol |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | capsule |
| Unit dose unit of measure | capsule |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Tapentadol phosphate |
| Basis of pharmaceutical strength | Based on Base Substance |
| Basis of strength substance identifier | 441757005 |
| Strength value numerator | 250.000 |
| Strength value numerator unit | mg |
| Ontology Drug Form & Route | |
| Form & Route | capsulemodified-release.oral |
| Dose Form | |
| Formulation | Modified-release capsule |
| Drug Route | |
| Route | Oral |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | Schedule 2 (CD) |
| Actual Medicinal Products | |
| Tapimio 250mg modified-release capsules (Neuraxpharm UK Ltd) | |
| Virtual Medicinal Product Packs | |
| Tapentadol 250mg modified-release capsules 56 capsule | |
dm+d data retrieved from TRUD: release NHSBSA_4.4.0_20240429000001, imported on 29th April 2024 at 05:07:25.